Biotechnology Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson’s Data – Sage Therapeutics (NASDAQ:SAGE) Read more
Biotechnology BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials – BioNTech (NASDAQ:BNTX) Read more